Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
University of Colorado, Denver
Fox Chase Cancer Center
University Health Network, Toronto
OHSU Knight Cancer Institute
Radiation Therapy Oncology Group
Duke University